Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies - Roberts, T; Kokai-Kun, J F; Coughlin, O (Clin Drug Investig, 2016)
et al.